BGB-3111-302
Completed
A Study Comparing BGB-3111 and Ibrutinib in Participants With Waldenström’s Macroglobulinemia (WM)
Protocol Summary
Study Overview
Sex:
All
Age: 18 Years / N/A
Accepts Healthy Volunteers? yes
Study Documents
Study Protocol Statistical Analysis Plan Plain Language SummaryStudy Overview
Sex:
All
Age: 18 Years / N/A
Accepts Healthy Volunteers? yes